Skip to main content
Article thumbnail
Location of Repository

Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor

By Iris Lee, Liqing Wang, Andrew D. Wells, Martin E. Dorf, Engin Ozkaynak and Wayne W. Hancock


Although certain chemokines and their receptors guide homeostatic recirculation of T cells and others promote recruitment of activated T cells to inflammatory sites, little is known of the mechanisms underlying a third function, migration of Foxp3+ regulatory T (T reg) cells to sites where they maintain unresponsiveness. We studied how T reg cells are recruited to cardiac allografts in recipients tolerized with CD154 monoclonal antibody (mAb) plus donor-specific transfusion (DST). Real-time polymerase chain reaction showed that intragraft Foxp3 levels in tolerized recipients were ∼100-fold higher than rejecting allografts or allografts associated with other therapies inducing prolonged survival but not tolerance. Foxp3+ cells were essential for tolerance because pretransplant thymectomy or peritransplant depletion of CD25+ cells prevented long-term survival, as did CD25 mAb therapy in well-functioning allografts after CD154/DST therapy. Analysis of multiple chemokine pathways showed that tolerance was accompanied by intragraft up-regulation of CCR4 and one of its ligands, macrophage-derived chemokine (CCL22), and that tolerance induction could not be achieved in CCR4−/− recipients. We conclude that Foxp3 expression is specifically up-regulated within allografts of mice displaying donor-specific tolerance, that recruitment of Foxp3-expressing T reg cells to an allograft tissue is dependent on the chemokine receptor, CCR4, and that, in the absence of such recruitment, tolerizing strategies such as CD154 mAb therapy are ineffectual

Topics: Brief Definitive Report
Publisher: The Rockefeller University Press
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. 1044 TGF-beta regulates in vivo expansion of Foxp3-expressing CD4 CD25 regulatory T cells responsible for protection against diabetes.
  2. A key role for CC chemokine receptor 4 in lipopolysaccharideinduced endotoxic shock.
  3. (1998). Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes.
  4. (2000). B7/CD28 costimulation is essential for the homeostasis of the CD4 CD25 immunoregulatory T cells that control autoimmune diabetes.
  5. (2003). Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.
  6. CD154 on the surface of CD4 CD25 regulatory T cells contributes to skin transplant tolerance.
  7. (2004). CD4 CD25 regulatory T cells suppress allograft rejection mediated by memory CD8 T cells via a CD30-dependent mechanism.
  8. cell costimulatory requirements in CD28-deficient mice.
  9. (2003). Chemokine receptor-dependent alloresponses.
  10. (2003). Control of regulatory T cell development by the transcription factor Foxp3.
  11. (2003). Conversion of peripheral CD4 CD25 naive T cells to CD4 CD25 regulatory T cells by TGF- induction of transcription factor Foxp3.
  12. (1996). Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection.
  13. Cutting edge: anti-CD154 therapeutic antibodies induce infectious transplantation tolerance.
  14. (2003). Foxp3 and natural regulatory T cells: key to a cell lineage?
  15. (2003). Foxp3 programs the development and function of CD4 CD25 regulatory T cells.
  16. (2002). Identification of regulatory T cells in tolerated allografts.
  17. (1995). Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.
  18. (1998). Immunologic self-tolerance maintained by CD25 CD4 naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.
  19. (2001). Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection.
  20. (1998). Indefinite survival of skin allografts in adult thymectomized, antilymphocyte serum-treated mice given bone marrow and thymus grafts of donor origin: tolerance induction by donor bone marrow and thymus.
  21. (2004). Inducible costimulator-dependent IL-10 production by regulatory T cells specific for self-antigen.
  22. (2004). Induction of foxP3 regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants.
  23. (2004). Promotion of allograft survival by CD4 CD25 regulatory T cells: evidence for in vivo inhibition of effector cell proliferation.
  24. (2003). Regulatory T cells in transplantation tolerance.
  25. (1993). Serologic analysis of a murine chemokine,
  26. (2004). Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.
  27. Stimulation of CD25( )CD4( ) regulatory T cells through GITR breaks immunological self-tolerance.
  28. (2004). TGF-beta 1 plays an important role in the mechanism of CD4 CD25 regulatory T cell activity in both humans and mice.
  29. (2001). Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4 CD25 regulatory T cells.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.